Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dedifferentiated chondrosarcoma of bone.

P J Daly1, F H Sim, L E Wold

  • 1Department of Orthopedics and the Section of Surgical Pathology, Rochester, Minnesota 55905.

Orthopedics
|May 1, 1989
PubMed
Summary

Dedifferentiated chondrosarcoma, a rare and aggressive cancer, arises from typical chondrosarcoma. Early detection via imaging is key, but prognosis remains poor despite treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Early Impact of COVID-19 on Urological Service Provision.

Irish medical journal·2021
Same author

Reconstruction of the hip after resection of periacetabular oncological lesions: a systematic review.

The bone & joint journal·2018
Same author

Ice Hockey Injuries.

The Physician and sportsmedicine·2016
Same author

Single centre experience of hypothermic machine perfusion of kidneys from extended criteria deceased heart-beating donors: a comparative study.

Irish journal of medical science·2014
Same author

Evaluation and management of unicompartmental osteoarthritis: role of arthroscopy in upper tibial osteotomy.

Orthopedics·2014
Same author

Pigmented villonodular synovitis.

Orthopedics·2014

Area of Science:

  • Orthopedic Oncology
  • Skeletal Radiology
  • Cancer Biology

Background:

  • Chondrosarcoma represents a group of malignant tumors arising from cartilage.
  • Dedifferentiated chondrosarcoma is a rare, aggressive subtype with poor outcomes.
  • Understanding dedifferentiation is crucial for improving patient prognosis.

Observation:

  • Approximately 11% of chondrosarcomas undergo dedifferentiation.
  • Radiographic findings may include a benign cartilage lesion adjacent to an aggressive, lytic lesion.
  • This imaging pattern suggests the transition to a more anaplastic state.

Findings:

  • Dedifferentiated chondrosarcoma exhibits a highly malignant behavior.
  • Prognosis remains unfavorable even after radical surgical intervention.
  • The 5-year survival rate is approximately 10%.

Implications:

  • Improved diagnostic criteria for early detection of dedifferentiation are needed.
  • Novel therapeutic strategies are required to improve survival rates.
  • Further research into the molecular mechanisms of chondrosarcoma dedifferentiation is warranted.

Related Experiment Videos